Health + Wellness
December 01, 2011
CLEVELAND - A mutation on the surface of human red blood cells provides protection against malaria caused by the parasite Plasmodium vivax, research led by Case Western Reserve University School of Medicine shows. The minute change, at a single position of red blood cell surface protein called the…
November 30, 2011
One of the earliest known impairments caused by Alzheimer’s disease—loss of sense of smell—can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a Case Western Reserve University School of Medicine researcher finds. The study confirms that the…
November 28, 2011
Case Western Reserve University School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart rhythm. AF is…
November 22, 2011
CLEVELAND - Case Western Reserve University School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart…
November 14, 2011
CLEVELAND - University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting…
November 14, 2011
A new study of teens undergoing substance abuse treatment finds helping others helps the adolescent helper by reducing cravings for alcohol and drugs, a major precipitator of relapse. These novel findings stem from the “Helping Others” study (helpingotherslivesober.org) led by Maria Pagano, PhD,…
November 10, 2011
CLEVELAND - Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio, which is co-sponsored by Case Western Reserve University School of Medicine. More than 80 abstracts will be presented at the annual…
November 07, 2011
CLEVELAND - Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin – Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals…
November 02, 2011
CLEVELAND - Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients.…
November 01, 2011
Research from Case Western Reserve University School of Dental Medicine to study an isolated agent from common oral bacteria may hold the answer as to how human beta defensins (HBDs)—nature’s way of keeping oral microbes from entering the body and wreaking havoc on our health—can be used to create…